Related Experiment Video
Updated: Aug 26, 2025

Flow Cytometry Analysis of Immune Cells Within Murine Aortas
Published on: July 1, 2011
Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis
Qiong Wang1, Yurong Wang1, Danyan Xu2
1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
Insights
Immune cells like helper T17 (Th17) and regulatory T cells (Tregs) significantly impact atherosclerosis. Imbalances in Th17/Treg cells and their associated cytokines, such as IL-17, influence disease progression and plaque stability.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Inflammation Biology
Background:
- Atherosclerosis, a primary cause of coronary heart disease, is characterized by chronic arterial wall inflammation.
- Immune cells critically influence the inflammatory processes driving atherosclerosis progression and outcomes.
Purpose of the Study:
- To review the mechanisms of CD4+ T cell subsets, specifically helper T17 (Th17) cells and regulatory T cells (Tregs), in regulating atherosclerosis.
- To focus on the roles of interleukin-17 (IL-17), IL-10, and other cytokines in atherosclerosis and the factors affecting their influence.
Main Methods:
- Literature review of immunological mechanisms in atherosclerosis.
- Analysis of the interplay between Th17 cells, Tregs, and cytokine profiles.
- Examination of factors modulating cytokine effects in the context of atherosclerosis.
Main Results:
- Interleukin-17 (IL-17), secreted by Th17 cells, can promote atherosclerosis but may also stabilize plaques.
- Regulatory T cells (Tregs) exhibit a protective role in atherosclerosis.
- An imbalance between Th17 and Treg cells is significantly implicated in atherosclerosis pathogenesis.
Conclusions:
- Immune responses are crucial regulators of atherosclerosis.
- Understanding immune cell mechanisms offers potential therapeutic targets for atherosclerosis.
- Further research is essential to fully elucidate these mechanisms and support clinical drug development.
Background:
Coronary heart disease due to atherosclerosis is the leading cause of death worldwide. Atherosclerosis is considered a chronic inflammatory state in the arterial wall that promotes disease progression and outcome, and immune cells play an important role in the inflammatory process.
Purpose:
We review the mechanisms of CD4+ T subsets, i.e., helper T17 (Th17) cells and regulatory T cells (Tregs), in regulating atherosclerosis, focusing on the role of interleukin (IL)-17, IL-10, and other cytokines in this disease and the factors influencing the effects of these cytokines.
Results:
IL-17 secreted by Th17 cells can promote atherosclerosis, but few studies have reported that IL-17 can also stabilize atherosclerotic plaques. Tregs play a protective role in atherosclerosis, and Th17/Treg imbalance also plays an important role in atherosclerosis.
Conclusion:
The immune response is important in regulating atherosclerosis, and studying the mechanism of action of each immune cell on atherosclerosis presents directions for the treatment of atherosclerosis. Nevertheless, the current studies are insufficient for elucidating the mechanism of action, and further in-depth studies are needed to provide a theoretical basis for clinical drug development.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Atherosclerosis I: Introduction
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

